Literature DB >> 22226803

A new preservation solution for lung transplantation: evaluation in a porcine transplantation model.

Nikolaus Pizanis1, Andrey Petrov, Jens Heckmann, Ingrid Wiswedel, Jeremias Wohlschläger, Herbert de Groot, Heinz Jakob, Ursula Rauen, Markus Kamler.   

Abstract

BACKGROUND: Lung preservation injury is still a major problem in lung transplantation. The aim of the current study was to evaluate the effects of a new preservation solution (Custodiol-N) for lung preservation.
METHODS: Using an in vivo pig model, 7 lungs each were preserved for 24 hours after perfusion with: low-potassium dextran (LPD) solution as control (Group I); base solution of Custodiol-N without iron chelators (Group II); Custodiol-N (Group III); or Custodiol-N supplemented with dextran 40 (Group IV). Four animals received a sham operation. After left lung transplantation and contralateral lung exclusion, hemodynamics and blood gases were monitored for 6 hours; tissue samples were taken at the end of the experiments.
RESULTS: All animals survived the transplantation procedure. Base solution- and Custodiol-N-preserved lungs (Groups II and III) showed graft function similar to that of LPD-preserved lungs (Group I), showing a trend toward improved values. Custodiol-N with dextran (Group IV) led to a significant reduction of mean pulmonary arterial pressure (20 ± 2 vs 28 ± 3 mm Hg, p < 0.01) and pulmonary vascular resistance (410 ± 51 vs 588 ± 83 dyne/s/cm(5), p < 0.01), and oxygenation ratio was significantly higher (536 ± 52 vs 313 ± 107 mm Hg at 6 hours, p < 0.01) and PCO(2) values were significantly lower (51 ± 9 vs 77 ± 5 mm Hg at 6 hours, p < 0.01) at 6 hours compared with LPD (Group I). Custodiol-N (Groups II to IV) showed a trend toward a lower wet/dry ratio and reduced oxidative stress; in the presence of dextran (Group IV), the difference was again statistically significant, when compared with LPD (Group I).
CONCLUSIONS: Custodiol-N solution is a new alternative preservation solution for lung transplantation that offers significantly superior protection compared with LPD when dextran 40 is added. Copyright Â
© 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226803     DOI: 10.1016/j.healun.2011.11.009

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  Lung inflation with hydrogen during the cold ischemia phase decreases lung graft injury in rats.

Authors:  Rongfang Liu; Xianhai Fang; Chao Meng; Jingchun Xing; Jinfeng Liu; Wanchao Yang; Wenzhi Li; Huacheng Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

Review 2.  Machine perfusion in solid organ transplantation: where is the benefit?

Authors:  Helge Bruns; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2014-01-16       Impact factor: 3.445

3.  Use of modified Custodiol-N as perfusion solution in ex vivo lung perfusion.

Authors:  Carolin Olbertz; Nikolaus Pizanis; Hagen Bäumker; Katharina Kalka; Clemens Aigner; Ursula Rauen; Ingo Nolte; Markus Kamler; Achim Koch
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

Review 4.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

5.  Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.

Authors:  Gábor Veres; Tamás Radovits; Béla Merkely; Matthias Karck; Gábor Szabó
Journal:  J Cardiothorac Surg       Date:  2015-02-28       Impact factor: 1.637

6.  Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients.

Authors:  Vinzeigh N Leukes; Stephanus T Malherbe; Andriette Hiemstra; Leigh A Kotze; Kelly Roos; Alana Keyser; Dalene De Swardt; Andrea Gutschmidt; Gerhard Walzl; Nelita du Plessis
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 7.  Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.

Authors:  Vinzeigh Leukes; Gerhard Walzl; Nelita du Plessis
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

Review 8.  HTK-N: Modified Histidine-Tryptophan-Ketoglutarate Solution-A Promising New Tool in Solid Organ Preservation.

Authors:  Annika Mohr; Jens G Brockmann; Felix Becker
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

9.  Custodiol-MP for ex vivo lung perfusion - A comparison in a porcine model of donation after circulatory determination of death.

Authors:  Katharina Kalka; Zoe Keldenich; Henning Carstens; Björn Walter; Ursula Rauen; Arjang Ruhparwar; Alexander Weymann; Markus Kamler; Gerald Reiner; Achim Koch
Journal:  Int J Artif Organs       Date:  2021-02-02       Impact factor: 1.595

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.